Skip to content

Pfizer Stock Up, Arena Stock Soars On Merger – Investor’s Business Daily

Pfizer Stock Up, Arena Stock Soars On Merger  Investor’s Business DailyPfizer bets on Arena Pharmaceuticals’ promising bowel disease treatment in $6.7 billion deal  CNBCPfizer to acquire Arena Pharmaceuticals for $6.7 billion  Yahoo FinanceEli Lilly’s Van Naarden hands $380M cash to Flagship-backed upstart in major new oncology deal  Endpoints NewsARENA PHARMACEUTICALS ALERT: Bragar Eagel & Squire, PC  GlobeNewswireView Full Coverage on Google News

Leave a Reply

Your email address will not be published. Required fields are marked *